PET [18F]mefway studies were performed on 17 (6 m, 11f) rhesus monkeys using a 3-injection protocol that included partial saturation injections of mefway. Compartmental modeling was performed using a model to account for non-tracer doses of mefway for the estimation of KDapp and Bmax. BPND estimates were also acquired from the first injection (high specific activity [18F]mefway, 90-minute duration) for comparison using the cerebellum (CB) as a reference region. Regions of interest were selected in 5-HT1A binding regions of the hippocampus (Hp), dorsal anterior cingulate cortex (dACC), amygdala (Am), and raphe nuclei (RN).
Female subjects displayed significantly (*p < 0.05) lower KDapp in the Hp (? 32 % ), Am (? 38 % ), and RN (? 37 % ). Only the Hp displayed significant differences in Bmax with females having a Bmax of ? 29 % compared to males. Male subjects demonstrated significantly lower BPND measurements in the Am (14 % ) and RN (29 % ).
These results suggest that the higher BPND values found in females are the result of lower [18F]mefway KDapp. Although a more experimentally complex measurement, separate assay of KDapp and Bmax provides a more sensitive measure than BPND to identify the underlying differences between females and males in 5-HT1A function.